About the Research Program

Mission

The mission of this group (CBRG) is to engage basic and clinical scientists as well as epidemiologists and biostatisticians in a search for and validation of promising early cancer biomarkers. To do so, the group supports and facilitates a broad spectrum of national and international research activities in cancer biology, particularly for the discovery of biomarkers for risk prediction and early detection of cancer. The CBRG also supports the development of databases and informatics systems to optimize tracking and assessment of biomarker utility and expression patterns. By facilitating, promoting, and coordinating research with the latest developments in technology and molecular circuitry of preneoplastic cells, the CBRG is committed to providing mechanistic predictors of preneoplastic progression and tools for effective cancer prevention. Our mission is accomplished through focused program portfolios, including grants, contracts, and program-initiated research.

Staff

• Sharmistha Ghosh-Janjigian, PhD
• Annalisa Gnoleba
• Jacob Kagan, PhD
• Karl Krueger, PhD
• Jocelyn Lee, PhD
• Kathy Marshall
• Richard Mazurchuk, PhD
• Christos Patriotis, PhD
• Jo Ann Rinaudo, PhD
• Lynn Sorbara, PhD
• Sudhir Srivastava, PhD, MPH
• Norwood Uzzell
• Nadarajen Vydelingum, PhD
• Paul Wagner, PhD
• Wendy Wang, PhD, MSc

Phone

(240) 276-7040

U.S. Mail Address

Cancer Biomarkers Research Group
Division of Cancer Prevention
National Cancer Institute
9609 Medical Center Drive
Rockville, MD 20850

Commercial Delivery Address

Cancer Biomarkers Research Group
Division of Cancer Prevention
National Cancer Institute
9609 Medical Center Drive
Rockville, MD 20850

Back to top